Latest News
Cerba HealthCare (Cerba HealthCare), together with Partners Group, a global private markets firm, and the Public Sector Pension Investment Board (PSP Investments), one of Canada’s largest pension investment managers, has entered into exclusive discussions with the EQT IX fund (EQT Private Equity) to enable the Company to continue its long-term innovation services strategy and enhance services for patients and the medical community.
Cerba HealthCare, headquartered in France and firmly established in Europe and Africa through its historical routine and specialty biology expertise, also operates globally through its clinical trials business unit for the validation of new compounds and vaccines. The
- 31/03/2021
Mid Europa Partners (Mid Europa) is to acquire UAB Pigu (Piqu), an e-ccomerce platform focussed on the Baltic countries.
Additionally, Mid Europa has agreed with MCI.Euroventures and the founding shareholders of Pigu and Hobby Hall Group OÜ (HHG) to combine Pigu and HHG to create one of the leading e-commerce and online marketplace platforms operating across Lithuania, Latvia, and Estonia with a growing presence in Finland.
Mid Europa will emerge as the majority shareholder supported by MCI.Euroventures (MCI buyout fund) and the two founding shareholders of Pigu and HHG retaining significant stakes in the combined Group. The transaction, which
- 31/03/2021
Maven Capital Partners (Maven) has led a GBP1.5 million investment in Boiler Plan (UK) Ltd (Boiler Plan), an online platform that sells, installs and services boilers across the UK.
- 31/03/2021
MPMF Fund Management (Ireland) Limited (MPMF), the Maples Group’s alternative investment fund manager and UCITS management company, has appointed industry expert, Declan McHugh who will have overall responsibility for MPMF’s business in Ireland.
An evolving regulatory environment, new and extensive authorisation, operational and transparency requirements, and increasing demands from regulators and investors have made operational efficiency more important than ever. At the same time, the management company space has rapidly matured and has become increasingly integrated with investment manager operations. Given these dynamics, fund managers are looking for holistic solutions – including management company, legal, fiduciary and fund services –
- 31/03/2021
- 31/03/2021
Citizens M&A Advisory served as the exclusive financial advisor to Telestream in its acquisition of Masstech.
Telestream, a portfolio company of Genstar Capital, is a vertical market software business focused on the video space and is a global leader in media workflow orchestration, media streaming and delivery technologies. Masstech, based in Whiteley, England, and a portfolio company of FPE Capital, is a provider of hybrid cloud-based storage and asset lifecycle management solutions for the media and entertainment industry. It represents Telestream’s 10th acquisition, coming shortly after its purchase of EcoDigital.
Telestream develops products for media processing and workflow orchestration;
- 31/03/2021
Blue Point Capital Partners (Blue Point) and its Blue Point IV portfolio company, VRC Engineered Solutions (VRC), has acquired Cascadia Custom Molding (Cascadia). The acquisition will expand VRC’s product offerings and geographic footprint while enhancing manufacturing capabilities and diversifying end markets served.
For over 40 years, Cascadia has provided high-quality thermoplastic components to highly regulated and attractive markets such as medical, aerospace and consumer goods. Cascadia operates out of manufacturing facilities in Coeur d’Alene, Idaho, and Woodinville, Wash. The acquisition will expand VRC’s manufacturing footprint into the Pacific Northwest, offering increased capability and flexibility for both VRC and its customers.
- 30/03/2021
Allvue Systems (Allvue), a specialist alternative investment technology solutions provider, has agreed with GOT YOUR BACK to provide fund accounting software for its alternatives fund management clients. GOT YOUR BACK is a specialist fund and corporate services provider based in Sweden whose clients include managers of private equity and other alternative investment funds.
Allvue will deliver its comprehensive Fund Accounting solution, enabling GOT YOUR BACK to streamline and seamlessly manage record-keeping and reporting for customers. The solution includes a robust platform that utilises cloud-based architecture to handle the most complex fund structures and accounting requirements.
“When evaluating software providers, we
- 30/03/2021
The Riverside Company, a global private equity firm focused on the smaller end of the middle market, has invested in a home health company in Greater Los Angeles.
This is an add-on investment to Riverside’s Best Life Brands, LLC (BLB), a family of companies focused on the well-being of clients along the continuum of senior care. With plans to begin franchising the concept immediately, the acquisition also marks the company’s entry into home health franchising. The company will be rebranded with a new name in the coming months. This is BLB’s fourth brand and expands upon the company’s plan to
- 30/03/2021
LIVEKINDLY Collective, a collection of heritage and start-up brands on track to become one of the world’s largest plant-based food companies, has completed a capital raise led by The Rise Fund, a global impact investing platform managed by TPG.
This round was joined by Rabo Corporate Investments, the investment arm of Rabobank, investing again in this round, S2G Ventures, and other existing and additional mission-aligned investors.
This investment closes a growth funding round of USD335 million, including USD135 million converted from a prior round, bringing the total funds raised by LIVEKINDLY Collective in its first year to USD535 million.
- 30/03/2021
- 30/03/2021
Arix Bioscience (Arix), a global venture capital company focused on investing in and building breakthrough biotech companies, has invested in Pyxis Oncology (Pyxis). As part of the deal, Arix Managing Director Christian Schetter will join Pyxis’ Board of Directors.
Pyxis is building a differentiated portfolio of biologics, including antibody-drug conjugates (ADCs) and immunotherapies, to improve the lives of patients with difficult-to-treat cancers.
Pyxis will use the proceeds from the financing to advance its differentiated portfolio of ADCs, a growing class of therapies that deliver highly potent targeted treatments directly to cancer cells. Pyxis will also continue advancing its immuno-oncology pipeline
- 30/03/2021
Special Reports
Featured
- Intel
- May 10, 2024
- Intel
- May 9, 2024
- Intel
- May 8, 2024
- Intel
- May 7, 2024
- Intel
- May 3, 2024
Events
16 May, 2024 – 8:30 am
16 May, 2024 – 5:30 pm
05 June, 2024 – 8:30 am
12 September, 2024 – 8:30 am
